Authors:
Xiang, R
Silletti, S
Lode, HN
Dolman, CS
Ruehlmann, JM
Niethammer, AG
Pertl, U
Gillies, SD
Primus, FJ
Reisfeld, RA
Citation: R. Xiang et al., Protective immunity against human carcinoembryonic antigen (CEA) induced by an oral DNA vaccine in CEA-transgenic mice, CLIN CANC R, 7(3), 2001, pp. 856S-864S
Authors:
Niethammer, A
Gaedicke, G
Lode, HN
Wrasidlo, W
Citation: A. Niethammer et al., Synthesis and preclinical characterization of a paclitaxel prodrug with improved antitumor activity and water solubility, BIOCONJ CHE, 12(3), 2001, pp. 414-420
Authors:
Shabat, D
Lode, HN
Pertl, U
Reisfeld, RA
Rader, C
Lerner, RA
Barbas, CF
Citation: D. Shabat et al., In vivo activity in a catalytic antibody-prodrug system: Antibody catalyzed etoposide prodrug activation for selective chemotherapy, P NAS US, 98(13), 2001, pp. 7528-7533
Authors:
Xiang, R
Primus, FJ
Ruehlmann, JM
Niethammer, AG
Silletti, S
Lode, HN
Dolman, CS
Gillies, SD
Reisfeld, RA
Citation: R. Xiang et al., A dual-function DNA vaccine encoding carcinoembryonic antigen and CD40 ligand trimer induces T cell-mediated protective immunity against colon cancerin carcinoembryonic antigen-transgenic mice, J IMMUNOL, 167(8), 2001, pp. 4560-4565
Authors:
Pertl, U
Luster, AD
Varki, NM
Homann, D
Gaedicke, G
Reisfeld, RA
Lode, HN
Citation: U. Pertl et al., IFN-gamma-inducible protein-10 is essential for the generation of a protective tumor-specific CD8 T cell response induced by single-chain IL-12 gene therapy, J IMMUNOL, 166(11), 2001, pp. 6944-6951
Authors:
Niethammer, AG
Xiang, R
Ruehlmann, JM
Lode, HN
Dolman, CS
Gillies, SD
Reisfeld, RA
Citation: Ag. Niethammer et al., Targeted interleukin 2 therapy enhances protective immunity induced by an autologous oral DNA vaccine against murine melanoma, CANCER RES, 61(16), 2001, pp. 6178-6184
Authors:
Lode, HN
Dreier, T
Xiang, R
Varki, NM
Kang, AS
Reisfeld, RA
Citation: Hn. Lode et al., Gene therapy with a single chain interleukin 12 fusion protein induces T cell-dependent protective immunity in a syngeneic model of murine neuroblastoma (vol 95, pg 2475, 1998), P NAS US, 97(7), 2000, pp. 3782-3782
Authors:
Xiang, R
Lode, HN
Chao, TH
Ruehlmann, JM
Dolman, CS
Rodriguez, F
Whitton, JL
Overwijk, WW
Restifo, NP
Reisfeld, RA
Citation: R. Xiang et al., An autologous oral DNA vaccine protects against murine melanoma (vol. 97, pg. 5492, 2000), P NAS US, 97(23), 2000, pp. 12932-12932
Authors:
Balicki, D
Reisfeld, RA
Pertl, U
Beutler, E
Lode, HN
Citation: D. Balicki et al., Histone H2A-mediated transient cytokine gene delivery induces efficient antitumor responses in murine neuroblastoma, P NAS US, 97(21), 2000, pp. 11500-11504
Authors:
Lode, HN
Xiang, R
Pertl, U
Forster, E
Schoenberger, SP
Gillies, SD
Reisfeld, RA
Citation: Hn. Lode et al., Melanoma immunotherapy by targeted IL-2 depends on CD4(+) T-cell help mediated by CD40/CD40L interaction, J CLIN INV, 105(11), 2000, pp. 1623-1630
Authors:
Lode, HN
Moehler, T
Xiang, R
Jonczyk, A
Gillies, SD
Cheresh, DA
Reisfeld, RA
Citation: Hn. Lode et al., Synergy between an antiangiogenic integrin alpha(v) antagonist and an antibody-cytokine fusion protein eradicates spontaneous tumor metastases, P NAS US, 96(4), 1999, pp. 1591-1596
Authors:
Lode, HN
Xiang, R
Duncan, SR
Theofilopoulos, AN
Gillies, SD
Reisfeld, RA
Citation: Hn. Lode et al., Tumor-targeted IL-2 amplifies T cell-mediated immune response induced by gene therapy with single-chain IL-12, P NAS US, 96(15), 1999, pp. 8591-8596